List of Tables
Table 1. Anti-Infective Drugs Market Trends
Table 2. Anti-Infective Drugs Market Drivers & Opportunity
Table 3. Anti-Infective Drugs Market Challenges
Table 4. Anti-Infective Drugs Market Restraints
Table 5. Global Anti-Infective Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anti-Infective Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Anti-Infective Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Anti-Infective Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Anti-Infective Drugs
Table 10. Global Anti-Infective Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Anti-Infective Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Anti-Infective Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Anti-Infective Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Anti-Infective Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Anti-Infective Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Anti-Infective Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Anti-Infective Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Anti-Infective Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Anti-Infective Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Anti-Infective Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Anti-Infective Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Anti-Infective Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Anti-Infective Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Anti-Infective Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Anti-Infective Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Anti-Infective Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Anti-Infective Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Anti-Infective Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline Basic Information List
Table 32. GlaxoSmithKline Description and Business Overview
Table 33. GlaxoSmithKline Anti-Infective Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Anti-Infective Drugs Business of GlaxoSmithKline (2019-2024)
Table 35. GlaxoSmithKline Recent Developments
Table 36. Merck Basic Information List
Table 37. Merck Description and Business Overview
Table 38. Merck Anti-Infective Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Anti-Infective Drugs Business of Merck (2019-2024)
Table 40. Merck Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Anti-Infective Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Anti-Infective Drugs Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Novartis AG Basic Information List
Table 47. Novartis AG Description and Business Overview
Table 48. Novartis AG Anti-Infective Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Anti-Infective Drugs Business of Novartis AG (2019-2024)
Table 50. Novartis AG Recent Developments
Table 51. Gilead Sciences Basic Information List
Table 52. Gilead Sciences Description and Business Overview
Table 53. Gilead Sciences Anti-Infective Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Anti-Infective Drugs Business of Gilead Sciences (2019-2024)
Table 55. Gilead Sciences Recent Developments
Table 56. Abbott Basic Information List
Table 57. Abbott Description and Business Overview
Table 58. Abbott Anti-Infective Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Anti-Infective Drugs Business of Abbott (2019-2024)
Table 60. Abbott Recent Developments
Table 61. Sanofi-Aventis Basic Information List
Table 62. Sanofi-Aventis Description and Business Overview
Table 63. Sanofi-Aventis Anti-Infective Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Anti-Infective Drugs Business of Sanofi-Aventis (2019-2024)
Table 65. Sanofi-Aventis Recent Developments
Table 66. Bristol-Myers Squibb Basic Information List
Table 67. Bristol-Myers Squibb Description and Business Overview
Table 68. Bristol-Myers Squibb Anti-Infective Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Anti-Infective Drugs Business of Bristol-Myers Squibb (2019-2024)
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Johnson Basic Information List
Table 72. Johnson Description and Business Overview
Table 73. Johnson Anti-Infective Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Anti-Infective Drugs Business of Johnson (2019-2024)
Table 75. Johnson Recent Developments
Table 76. Roche Pharma AG Basic Information List
Table 77. Roche Pharma AG Description and Business Overview
Table 78. Roche Pharma AG Anti-Infective Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Anti-Infective Drugs Business of Roche Pharma AG (2019-2024)
Table 80. Roche Pharma AG Recent Developments
Table 81. Nanosphere Basic Information List
Table 82. Nanosphere Description and Business Overview
Table 83. Nanosphere Anti-Infective Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Anti-Infective Drugs Business of Nanosphere (2019-2024)
Table 85. Nanosphere Recent Developments
Table 86. NanoViricides Basic Information List
Table 87. NanoViricides Description and Business Overview
Table 88. NanoViricides Anti-Infective Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Anti-Infective Drugs Business of NanoViricides (2019-2024)
Table 90. NanoViricides Recent Developments
Table 91. Novabay Pharmaceuticals Basic Information List
Table 92. Novabay Pharmaceuticals Description and Business Overview
Table 93. Novabay Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Anti-Infective Drugs Business of Novabay Pharmaceuticals (2019-2024)
Table 95. Novabay Pharmaceuticals Recent Developments
Table 96. Obetech Basic Information List
Table 97. Obetech Description and Business Overview
Table 98. Obetech Anti-Infective Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Anti-Infective Drugs Business of Obetech (2019-2024)
Table 100. Obetech Recent Developments
Table 101. Optimer Pharmaceuticals Basic Information List
Table 102. Optimer Pharmaceuticals Description and Business Overview
Table 103. Optimer Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Anti-Infective Drugs Business of Optimer Pharmaceuticals (2019-2024)
Table 105. Optimer Pharmaceuticals Recent Developments
Table 106. Basilea Pharmaceutica AG Basic Information List
Table 107. Basilea Pharmaceutica AG Description and Business Overview
Table 108. Basilea Pharmaceutica AG Anti-Infective Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Anti-Infective Drugs Business of Basilea Pharmaceutica AG (2019-2024)
Table 110. Basilea Pharmaceutica AG Recent Developments
Table 111. Daiichi Sankyo Basic Information List
Table 112. Daiichi Sankyo Description and Business Overview
Table 113. Daiichi Sankyo Anti-Infective Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Anti-Infective Drugs Business of Daiichi Sankyo (2019-2024)
Table 115. Daiichi Sankyo Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Anti-Infective Drugs Downstream Customers
Table 119. Anti-Infective Drugs Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Anti-Infective Drugs Product Picture
Figure 2. Global Anti-Infective Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Anti-Infective Drugs Report Years Considered
Figure 5. Global Anti-Infective Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Infective Drugs Revenue in 2023
Figure 7. Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. OTC Picture
Figure 9. Rx Drugs Picture
Figure 10. Global Anti-Infective Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Anti-Infective Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Drugs Store
Figure 14. Product Picture of Other
Figure 15. Global Anti-Infective Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Anti-Infective Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Anti-Infective Drugs Sales Value (%), (2019-2030)
Figure 28. United States Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030
Figure 34. China Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030
Figure 36. China Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. India Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. India Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. Anti-Infective Drugs Industrial Chain
Figure 50. Anti-Infective Drugs Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
